KEYMED BIO-B_Providing professional financial news and data related to KEYMED BIO-B, committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

KEYMED BIO-B (02162.HK): CM512 (TSLP/IL-13 Bispecific Antibody) Granted Breakthrough Therapy Designation by NMPA

Tags：

KEYMED BIO-B 02162.HK CDE Breakthrough Therapy

2026-07-23

Research
Autonomous Driving Concept Stocks Watch | RoboSense (02498.HK) Trades Sluggishly in Afternoon; Four Strategic Cooperation Deals Signed During WAIC
ETF
ChinaAMC NASDAQ 100 ETF(03086.HK) Edges Up 0.17% Intraday, Average Trading Price at HK$59.214
ETF
Samsung S&P Gsci Crude Oil Er Futures Etf(03175.HK) Rises 0.39% Intraday to HK$10.42
ETF
Mirae Asset Horizons S&P Crude Oil Futures Enhanced Er Etf(03097.HK) Rises 0.46% Intraday with Turnover Rate of 2.12%
ETF
iShares Core MSCI AC Asia ex Japan Index ETF(03010.HK) Jumps 1.78% Intraday, AUM Hits HK$36.816 Billion
ETF
Ishares Core Msci Taiwan Index Etf(03074.HK) Rises 1.01% Intraday, NAV Per Unit Stands at HK$458.259
ETF
CSOP SZSE CHINEXT ETF(03147.HK) Rises 1.25% Intraday with Average Trading Price of HK$14.519
ETF
Southern China A50 ETF (02822.HK) Rises 1.27% Intraday with AUM of HK$7.337 Billion
ETF
Tracker Fund Of Hong Kong(02800.HK) Rises 1.42% Intraday, Net Asset Value Per Unit at HK$25.369
ETF
Ishares Core Hang Seng Index Etf(03115.HK) Rises 1.62% Intraday with Average Trading Price of HK$92.461

Scan QR Code

Download App